Duke Clinical Research Institute

Running trials

• Active, not recruiting

  Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA

  NCT06868290· Phase 2· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Phase 2 Study of Rapcabtagene Autoleucel in Myositis

  NCT06665256· Phase 2· Novartis Pharmaceuticals· Source

• Active, not recruiting

  A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)

  NCT06581198· Phase 2· Novartis Pharmaceuticals· Source

• Active, not recruiting

  A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).

  NCT06412666· Phase 2/3· Cytokinetics· Source

• Recruiting

  Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors

  NCT05868629· Novartis Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers1 recruiting
• Sarcoma1 recruiting

Closed trials

• Terminated

  Pretomanid in Adults With Hepatic Impairment

  NCT02422524· Phase 1· National Institute of Allergy and Infectious Diseases (NIAID)· Source

• Completed

  Study of ISB 1342, a CD38/CD3 Bispecific Antibody, in Subjects With Previously Treated Multiple Myeloma

  NCT03309111· Phase 1· Ichnos Sciences SA· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Heart failure175 works · 0 trials
• Atrial fibrillation62 works · 0 trials
• Coronary artery disease34 works · 0 trials
• Idiopathic pulmonary fibrosis19 works · 0 trials
• Peripheral artery disease10 works · 0 trials
• Long COVID and ME/CFS10 works · 0 trials
• Postural tachycardia syndrome (POTS)3 works · 0 trials